RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors. Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sánchez V, Sanders ME, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gómez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM (2016) Clin Cancer Res 22: 1499-509 Too much of a good thing: How modulating LTB actions restore host defense in homeostasis or disease. Brandt SL, Serezani CH (2017) Semin Immunol 33: 37-43 mPGES1-Dependent Prostaglandin E (PGE) Controls Antigen-Specific Th17 and Th1 Responses by Regulating T Autocrine and Paracrine PGE Production. Maseda D, Johnson EM, Nyhoff LE, Baron B, Kojima F, Wilhelm AJ, Ward MR, Woodward JG, Brand DD, Crofford LJ (2018) J Immunol 200: 725-736 Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice. Bonami RH, Thomas JW (2015) J Immunol 195: 4730-41 Regulatory myeloid cells: an underexplored continent in B-cell lymphomas. Roussel M, Irish JM, Menard C, Lhomme F, Tarte K, Fest T (2017) Cancer Immunol Immunother 66: 1103-1111 Cell-based therapies in pulmonary hypertension: who, what, and when? Majka S, Burnham E, Stenmark KR (2011) Am J Physiol Lung Cell Mol Physiol 301: L9-L11 Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS. Stark R, Choi H, Koch S, Lamb F, Sherwood E (2015) Innate Immun 21: 565-74 Strategies to improve BCG vaccine efficacy. Bali P, Tousif S, Das G, Van Kaer L (2015) Immunotherapy 7: 945-8 Molecular mediators of mesenchymal stem cell biology. Alfaro MP, Saraswati S, Young PP (2011) Vitam Horm 87: 39-59
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.